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ABSTRACT 
 Curli are a class of functional amyloids, proteinaceous fibers secreted by many enteric 
bacteria. Curli help bacteria adhere to surfaces and colonize their hosts, and are an important 
component of biofilms, which increase bacterial resistance to antibiotics, desiccation, and other 
environmental stresses. The secretion and formation of curli fibers is a highly regulated process 
that is coordinated through the actions of many cellular proteins. The focus of my thesis is CsgE, 
a periplasmic protein that is thought to play a chaperone-like role in facilitating the secretion of 
the major curli subunit, CsgA, across the outer membrane. Purified CsgE has been shown to 
inhibit CsgA polymerization in vitro, suggesting that it helps prevent inappropriate 
amyloidogenesis in the cell. CsgE can also form a complex with CsgG, the outer membrane pore 
through which CsgA is secreted. CsgE has been shown to block the pore via some sort of gating 
mechanism, as demonstrated through erythromycin sensitivity assays. When CsgG alone is 
overexpressed, cells are susceptible to erythromycin as the antibiotic is able to enter the cell, 
but when CsgG is coexpressed with CsgE, erythromycin resistance is restored as CsgE plugs the 
outer membrane pore.  
 My thesis examines three point mutations in CsgE and how they impact CsgE function. 
Three mutants were constructed: a Trp-Ser mutation at the 49th amino acid (W49S), a Trp-Ser 
mutation at the 52nd amino acid (W52S), and a Phe-Ser mutation at the 68th amino acid (F68S). 
These mutants were then evaluated in vivo to determine their effects on curli formation and 
interactions with CsgG. I found that while the W49S and W52S mutants were still able to form 
curli fibers, the F68S mutant was not as able to form curli fibers but instead displayed an 
intermediate pink phenotype when plated on Congo red. Additionally, the F68S CsgE mutant 
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appeared in greater quantities when visualized on Western blot, suggesting that this mutant 
results a more stable protein configuration.  Next, a series of erythromycin sensitivity assays 
were performed assessing the ability of each mutant to interact with CsgG via a gating or 
blocking mechanism. Whereas the W49S and W52S mutants did not confer erythromycin 
resistance, the F68S mutant was able to confer resistance similar to or even greater than wild 
type. Thus, the mutation at the 68 site may be affecting the stability of CsgE in a way that 
enhances its ability to block CsgG, but interferes with its ability to act as a chaperone in 
facilitating the secretion of CsgA. The W49S and W52S mutants, on the other hand, were 
unable to block the CsgG pore, suggesting that these sites are important in forming the CsgE-
CsgG complex. These three sites offer promising insight into the crystal structure of CsgE and 
how the structure shapes its interactions with other proteins involved in curli secretion.   
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BACKGROUND AND INTRODUCTION 
 Amyloids are ordered, proteinaceous fibers characterized by the aggregation of 
peptides into β-sheet rich structures that are highly resistant to denaturation and digestion [1]. 
Protein misfolding and amyloid formation is the hallmark of several neurodegenerative diseases 
such as Parkinson’s, Alzheimer’s, and Huntington’s diseases [2-4]. However, amyloid formation 
does not always arise as the product of protein misfolding. A specific subset of amyloids called 
“functional amyloids” are assembled by nearly all cell types and organisms [5, 6]. Bacterial 
functional amyloids play a critical role in surface attachment and biofilm formation [7-9]. 
Biofilms are useful to bacteria for a variety of reasons. The barrier formed by the extracellular 
polymeric secretions serves to trap antimicrobial agents, protecting the cells within [7]. 
Additionally, biofilms allow for the existence of pockets of “dormant zones” containing bacteria 
that are alive but not actively growing and dividing. Since most antibiotics are only effective in 
the presence of cellular activity, having dormant zones allows for the survival of bacteria that 
can then continue perpetuating the biofilm. Finally, it has been hypothesized that small 
populations of super-resistant bacteria can exist that contribute to the overall resistance of the 
biofilm [10]. Biofilm formation is a highly coordinated and regulated process, and 
understanding the genes and proteins involved in biofilm formation and persistence can thus 
offer insight to potential targets to their eradication.  
Curli were the first identified functional amyloid and are produced by many enteric 
bacteria, including Escherichia coli and Salmonella spp [8, 9, 11]. Curli are non-branching 
proteinaceous fibers 4-12 nm wide, composed of a β-sheet rich structure that is resistant to 
denaturation and protease digestion [5]. They have been demonstrated to be the major 
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proteinaceous component of E. coli and Salmonella biofilms, with cellulose and polysaccharides 
representing the other biofilm components [11]. Curli are a useful and essential component of 
the biofilm, as curliated biofilms have been shown to have greater resistance to desiccation and 
treatment with hydrogen peroxide compared to non-curliated biofilms [12].  
In E. coli biofilms, curli production is delegated to a specific subpopulation of cells at the 
air-colony interface [13]. Thus, curli secretion is a highly controlled process that is influenced by 
many environmental factors. In addition, many cellular regulators and accessory proteins are 
involved to ensure that curli formation takes place at the desired place and time. Figure 1 
provides an overview of curli biogenesis. There are two divergently transcribed operons 
controlling curli secretion [14]. The first is the csgBAC operon, which encodes the major and 
minor curli subunits CsgA and CsgB respectively, as well as the periplasmic protein CsgC. CsgA, 
the major subunit, composes the curli fibers themselves. Like all amyloid fibers, purified CsgA is 
capable of self-polymerizing in vitro, and binds the amyloid-specific dyes Congo red and 
thioflavin T which allow for visualization of curli fibers [15]. CsgB, the minor curli subunit, is 
structurally similar to CsgA and nucleates fiber formation on the cell surface. CsgB from one cell 
is able to interact with soluble CsgA produced by other cells in a process called interbacterial 
complementation [16]. Both CsgA and CsgB are required for effective curli formation in vivo. 
CsgC is a small periplasmic protein that has been demonstrated to be a potent inhibitor of 
intracellular amyloid formation, and keeps the major and minor curli subunits from assembling 
inappropriately inside the cell [17].  
The second operon required for curli secretion is the csgDEFG operon, which encodes 
several accessory proteins required for successful curli formation. CsgD is a transcriptional 
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regulator responsible for regulating both curli operons. Insertions in csgD completely abolish 
transcription from the csgBAC operon, suggesting that regulatory effects on the csgDEFG 
operon affect both operons [14]. CsgE, CsgF, and CsgG are all accessory proteins that play a role 
in mediating and facilitating the secretion of the major and minor curli subunits across the 
outer membrane. CsgG is a lipoprotein that is localized to the outer membrane and facilitates 
the diffusion of CsgA out of the cell. Analysis of the crystal structure reveals that its 
configuration in the membrane consists of a cage-like β-barrel which permits the diffusion of 
peptides [18]. When overexpressed, CsgG can also act as a nonspecific channel through which 
periplasmic proteins can diffuse out of the cell or small molecules such as antibiotics can enter 
the cell [18, 19]. It has been shown that overexpression of CsgG leads to erythromycin 
sensitivity [19].  
CsgE and CsgF are chaperone-like proteins that work with CsgG to help facilitate the 
secretion of the curli subunits. Cells with a csgF deletion are still able to secrete soluble CsgA 
and donate CsgA to nearby cells for complementation, but are unable to form their own curli 
fibers. Thus, it is thought that CsgF is involved in the nucleation step of fiber formation, which 
takes place on the outer membrane. CsgF plays a role in the proper localization of CsgB and in 
mediating CsgB protease resistance [20].   
Whereas CsgF is localized to the outer membrane, CsgE remains inside the periplasm 
and is thought to play a chaperone-like role in coordinating the secretion of the major curli 
subunits through CsgG. Cells with a csgE deletion are defective for curli secretion and assembly 
[19]. Like CsgC, purified CsgE is able to inhibit CsgA polymerization in vitro, suggesting that it 
helps prevent inappropriate amyloidogenesis in the cell [19]. In addition to interacting with 
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CsgA, CsgE is also capable of forming a complex with CsgG that gates the pore [18, 19]. At 
saturated concentrations of CsgE, the pore is completely blocked, while at concentrations of 1 
nM or below, only transient interactions occur [18]. Thus, whereas overexpression of CsgG 
leads to erythromycin sensitivity, overexpression of CsgE confers erythromycin resistance 
through the blocking of the CsgG pore [19]. The exact mechanism by which CsgE blocks or gates 
CsgG is still uncertain, but this interaction likely plays a role in facilitating the secretion of CsgA.  
 
Figure 1: Overview of curli biogenesis. All Csg proteins (excluding CsgD) have Sec-
dependent signal sequences. CsgE and CsgC are periplasmic proteins required for efficient curli 
assembly. The major subunit protein (CsgA) and the nucleator (CsgB) are secreted to the cell 
surface in a CsgG/E-dependent fashion. CsgB associates with the outer membrane (and CsgF) 
where it nucleates soluble, CsgA into a highly ordered amyloid fiber. 
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My thesis focuses on CsgE and how mutations at three distinct sites affect the function 
of CsgE in vivo. CsgE is composed of 109 amino acids; of these, three have been identified as 
sites of interest thought to play an important role in its function and interactions with other 
proteins involved in curli secretion such as CsgG. Figure 2 illustrates these sites in the context of 
the 3-D structure of CsgE. The goal of these experiments was to create point mutations at each 
of these sites of interest and then evaluate the mutants to see how they affect CsgE function in 
vivo. The three mutants were a tryptophan to serine mutation at the 49th amino acid (W49S), a 
tryptophan to serine mutation at the 52nd amino acid (W52S), and a phenylalanine to serine 
mutation at the 68th amino acid (F68S). First, the ability of each of these mutants to 
complement curli formation was assessed through plating on Congo red. Western blots were 
carried out to compare levels of CsgG, CsgE, and CsgA between the mutants and wild type curli-
producing cells. Finally, a series of erythromycin sensitivity assays were performed to assess the 
ability of each mutant to interact with CsgG.  
 
 
 
 
 
 
 
 
Figure 2: Model of CsgE as solved by our collaborator, Christiane Ritter (unpublished results). 
The approximate location of each site is indicated.  
F68 
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W52 
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MATERIALS AND METHODS 
csgE mutants  
Three sites in csgE were assessed, and point mutations created at each. The first is at 
the 49th amino acid and consists of a tryptophan to serine mutation, thereafter referred to as 
W49S. The second is at the 52nd amino acid and consists of a tryptophan to serine mutation 
(W52S). The third is at the 68th position and consists of a phenylalanine to serine mutation 
(F68S). Mutations were introduced by fusion PCR and confirmed by sequencing.  
Strain construction  
 E. coli strain LSR11 is derived from parent strain MC4100, which is a laboratory strain of 
E. coli that is wild type for curli-producing genes. LSR11 is a csgE mutant that was created by 
removing the kanR cassette from LSR5 (MC4100 Δcsg::kanR) [19].  
Fusion PCR  
Fusion PCR was used to introduce the desired mutations into pLR12, a plasmid encoding 
both csgG and csgE. Custom primers were designed containing the desired mutation in csgE. 
The first round of PCR paired one of the mutation-containing primers with an outer csgE primer 
located just outside the csgE gene, resulting in a gene fragment containing the desired 
mutation. The second round of PCR took the fragments from the first round of PCR and 
incubated them with both outer primers, thus amplifying the entire gene now containing the 
mutation. The PCR products were then digested with BamHI and NcoI and ligated into pTrc99A, 
an empty vector. This plasmid was then transformed into E. coli strain LSR11.  
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Congo red plating  
 First, csgE was cloned into pLR2, which contains the csgBAC promoter, allowing csgE to 
be expressed under normal curli-inducing conditions. These plasmids were then transformed 
into strain LSR11. Congo red YESCA plates were prepared using 10g/L CAS amino acids, 1g/L 
yeast extract, and 20g/L agar. 200:1 Congo red stock was added when the plates were cooled. 4 
µl of cells normalized to 1 OD600 were then dotted onto the plates, streaked, and allowed to 
grow at 26°C for 48 hours.  
Western blot 
 For CsgA: Cells were collected after being grown on LB plates at 37°C overnight, 
suspended in water, and normalized to 1 OD600. For CsgA, treatment with formic acid or 
hexafluoroisopropanol (HFIP) is required to denature the fibers into monomers that can be 
resolved on an SDS-PAGE gel [15]. Thus, for each sample being blotted, two tubes were 
prepared: one for treatment with HFIP and the other to be untreated as a negative control. To 
treat with HFIP, the pelleted cells were resuspended in 75 µl HFIP, incubated at room 
temperature for 10 minutes, then the HFIP was dried in a vacuum centrifuge. Once the HFIP 
was completely evaporated, the cells were then resuspended in 40 µl 2X SDS buffer. The 
untreated cells were simply pelleted and resuspended in 40 µl 2X SDS buffer. All the samples 
were then boiled at 100°C for 10 minutes before being run on an SDS-PAGE gel. Protein was 
then transferred onto a PVDF membrane and blotted with primary antibody and a second 
fluorescent antibody.  
For CsgG/CsgE: For CsgG and CsgE, no treatment with formic acid or HFIP is necessary. 
Cells were collected after being grown on LB plates at 37°C overnight, normalized to 1 OD600, 
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and resuspended in 40 µl 2X SDS buffer. Samples were then boiled at 100°C for 10 minutes 
before being run on an SDS-PAGE gel. Protein was then transferred onto a PVDF membrane and 
blotted with primary antibody and a second fluorescent antibody.  
Erythromycin sensitivity assay 
 E. coli strain LSR11 containing pTrc99A (empty vector), PMC1 (WT CsgG), pLR12 (WT 
CsgG and WT CsgE), and plasmids containing each of the three mutations were used in this 
assay. Cells were grown overnight in LB, then diluted 1:100 into 10mL LB and grown at 37°C 
with shaking. Expression was induced with 0.05mM IPTG at 0.5 hr, and then 10 µg/ml 
erythromycin was added at 1 hr [19]. Optical density was measured once every 0.5 hour for 4 
hours. Optical density was measured using a Klett meter, which provides OD in Klett units.  
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RESULTS 
Observing how these mutations affect CsgE function in vivo offers insight to how these 
sites function in the context of the cell. In order to better understand how these three residues 
contribute to CsgE function, point mutations were created at each position and then the 
mutant csgE sequences cloned into pLR2, which contains the csgBAC promoter. This allows the 
mutant forms of CsgE to be expressed under normal curli-inducing conditions. The plasmids 
containing WT or mutant CsgE were then transformed into LSR11, a csgE deletion strain, so that 
their ability to complement curli formation could be assessed.  
The first step was to qualitatively assess how these mutations affected curli production 
by plating them on Congo red and observing the Congo red binding phenotype [16]. Congo red 
is an amyloid-specific dye that binds to polymerized fibers. MC4100 (WT curli-producing cells) 
appears red, whereas LSR11 (MC4100 csgE-), which is defective for curli production, appears 
white (Figure 3). The csgE- mutant complemented with either the W49S or W52S CsgE mutants 
displayed a red phenotype comparable to complementation with wild type CsgE (Figure 3A-C). 
However, complementation with the F68S CsgE mutant displayed an intermediate pink 
phenotype (Figure 3D), indicating that there was a defect in curli biogenesis when the F68S 
CsgE mutant protein was expressed.  
To better quantify the protein levels in each strain, Western blots were performed using 
antibodies specific against CsgA (the major curli subunit), CsgG (outer membrane secretion 
protein) and CsgE. CsgG levels remained fairly uniform between all the strains and plasmids 
assessed (Figure 4A-F). CsgE levels were measured using the α-CsgE antibody where CsgE was 
expressed from a plasmid. Note that the α-CsgE antibody is unable to recognize CsgE expressed 
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natively from the chromosome, possibly due to low levels of endogenous CsgE [21]. The W49S 
mutant and WT CsgE proteins accumulated to approximately the same levels (Figure 4CD). The 
W52S mutant appeared to have slightly elevated CsgE levels (Figure 4E), and the F68S mutant 
had significantly higher levels than WT CsgE (Figure 4F), suggesting that these mutations alter 
the steady state levels of CsgE. Polymerized CsgA fibers are resistant to denaturation, and must 
be treated with a strong denaturant such as hexaflurorisopropanol (HFIP) in order to be 
resolved on SDS-PAGE gel [15]. Figure 4 shows HFIP-treated samples alternating with untreated 
samples. Interestingly, CsgA levels for the W49S and W52S mutants were comparable to wild 
type (Figure 4C-E), although the F68S mutant had considerably less CsgA (Figure 4F).  
Following the Congo red plating and initial Western blots, it was apparent that the F68S 
mutant was unique from the other two mutants. The increased amounts of CsgE present on the 
Western blot suggest that the F68S mutation is causing the protein to take on a more stable 
configuration. However, it was unclear whether the decrease in curli fibers seen on Congo red 
was due to changes in how the F68S mutant was interacting with CsgG or CsgA. Thus, in order 
to gain a better understanding of how the CsgE mutants are able to gate CsgG, a series of 
erythromycin sensitivity assays were performed.  
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Figure 3: Congo red binding phenotype of csgE mutants compared to wild type (MC4100) and 
cells containing a csgE deletion (LSR11). Cells were streaked onto Congo red plates and grown 
at 26°C for 48 hours. MC4100 produces a bright red phenotype, whereas LSR11 has a white 
phenotype. a-c) The W49S and W52S mutants display a red phenotype comparable to the wild 
type. d) The F68S mutant, however, displays an intermediate pink phenotype. 
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Figure 4: CsgG, CsgE, and CsgA levels visualized by Western Blot. Cells were grown overnight on 
LB plates, collected and normalized to 1 OD600. To visualize CsgA, samples were treated with 
HFIP before being resuspended in SDS buffer, boiled, and run on an SDS-PAGE gel. CsgG and 
CsgE samples were simply resuspended in SDS buffer, boiled, and run on SDS-PAGE. CsgG levels 
are fairly uniform between wild type and the three mutants. For CsgE, the W49S mutant has 
protein levels similar to WT2 (d) (note that the α-CsgE antibody is unable to bind to CsgE from 
the wild type strain). TheW52S mutant has slightly more protein (e), and the F68S mutant has 
significantly more (f), indicating that these mutants may have a more stable configuration. CsgA 
levels are fairly uniform between wild type and the first two mutants, while the F68S mutant 
displays significantly less CsgA. Western blots were replicated at least three times with very 
similar results.  
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 The purpose of the erythromycin sensitivity assays was to evaluate the ability of the 
CsgE mutants to interact with CsgG via a gating mechanism. In order to allow CsgE and CsgG 
expression to be induced at the same time, the desired mutations were introduced into csgE via 
fusion PCR, and then both the csgE mutants and csgG were cloned into pTrc99A under the 
same promoter. The erythromycin sensitivity assays were carried out on LSR11 with pTrc99A 
(empty vector), pMC1 (WT CsgG only), pLR12 (WT CsgG and WT CsgE), and then plasmids 
carrying the mutant constructs in pTrc99A. The empty vector was mostly unaffected by the 
erythromycin, whereas cells expressing CsgG only were susceptible to erythromycin and died 
off quickly (Figure 5AB). The coexpression of WT CsgE with CsgG conferred erythromycin 
resistance (Figure 5C). The W49S and W52S mutants were highly susceptible to erythromycin 
and did not confer resistance (Figure 6AB). Their growth curves resemble that of CsgG alone 
(Figure 5B). The F68S mutant, however, did confer erythromycin resistance, and even slightly 
more so than WT CsgE (Figures 5C and 6C).  
 Western blots were also performed on the cells that underwent the erythromycin 
sensitivity assays in order to ensure that both CsgE and CsgG were being expressed, and to 
evaluate their levels in the cell. CsgG levels were uniform among all the cells (except the empty 
vector). CsgE levels were fairly uniform between the WT CsgE and W49S and W52S mutants 
that were not treated with erythromycin, although the F68S mutant again displayed slightly 
elevated levels. For the cells that were treated with erythromycin, a faint band of CsgE is visible 
for the wild type and F68S mutant, but no CsgE is visible for the W49S and W52S mutants 
(Figure 8).  
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Figure 5: Erythromycin sensitivity assay controls. a) Empty vector, which expresses neither CsgG 
nor CsgE, is mostly unaffected by erythromycin. b) Cells overexpressing CsgG are highly 
susceptible to killing by erythromycin. c) Cells expressing both CsgG and CsgE experience 
erythromycin resistance.  
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Figure 6: Erythromycin sensitivity assay with CsgE mutants. a-b) Expression of the W49S and 
W52S mutants do not confer resistance. c) However, expression of the F68S mutant does 
confer erythromycin resistance. 
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Figure 7: Summary of erythromycin sensitivity assays showing rescue ability of mutants 
compared to WT CsgG alone, and WT CsgG and CsgE with and without erythromycin. The F68S 
mutant (light blue) confers slightly more resistance than wild type (dark blue). The W49S and 
W52S mutants (green and purple) are approximately as susceptible as CsgG only (red).  
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Figure 8: CsgG and CsgE levels in cells after growth curve. Cells were collected after being 
grown with or without erythromycin treatment for four hours, normalized to 1 OD600, then 
pelleted and run on SDS-PAGE gel. CsgE is clearly present in the cells that were not treated with 
erythromycin, but are not present in the W49S and W52S strains that were treated with 
erythromycin (a). Once again, increased CsgE levels are seen in the F68s mutant. A faint band is 
visible for the F68S treated with erythromycin whereas no CsgE is present for the W49S and 
W52S mutants (b).   
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DISCUSSION 
Among the three mutants, the W49S and W52S mutants appear to result in relatively 
similar results for each assay performed, whereas the F68S mutant is markedly different. This 
was apparent in the Congo red binding phenotype of each mutant, where complementation 
with the W49S and W52S mutants displayed a Congo red phenotype similar to 
complementation with wild type plasmid (Figure 3A-C), and complementation with the F68S 
mutant displayed a unique intermediate phenotype (Figure 3D). This intermediate pink 
phenotype suggests that curli secretion and assembly is not completely inhibited, yet the fibers 
forming are certainly not as robust as wild type. Thus, interfering with the 68 site in CsgE 
impairs its ability to function in the secretion of CsgA, yet not to the degree of a csgE deletion 
mutant.  
There are several hypotheses that could explain the F68S mutant’s impaired curli 
formation. Firstly, this site could be important for the interactions between CsgE and CsgG, and 
a mutation at this site is causing it to block the pore in a way that does not allow CsgA through. 
Since F68S CsgE displayed greater stability as visualized by Western blot (Figure 4F), perhaps 
the increase in stability increases the favorability of its configuration with CsgG, thus clogging 
the pore and decreasing CsgA secretion. Another hypothesis is that the 68 site is important for 
its interactions with CsgA, and a mutation here is impairing the affinity of CsgE with CsgA, and 
its ability to act as a chaperone. As for the W49S and W52S mutants, even though they 
displayed Congo red binding comparable to wild type, it is uncertain just from the Congo red 
plating whether or not they are still able to function like WT CsgE in the gating mechanism with 
CsgG.  
24 
 
The erythromycin sensitivity assays were conducted to assess how the CsgE mutations 
affect their interaction with CsgG. It has been established that overexpression of CsgG leads to 
erythromycin sensitivity, whereas CsgE expression is able to restore resistance by gating the 
pore [19]. Thus, the “rescue” ability of CsgE to confer erythromycin resistance provides insight 
to the gating interaction that takes place between the two proteins. Figure 5BC demonstrates 
this rescue ability by comparing overexpression of CsgG alone to coexpression with WT CsgE.   
These assays were performed with plasmids expressing both WT CsgG and the mutant 
forms of CsgE (Figure 6A-C). The W49S and W52S mutants do not confer erythromycin 
resistance; the cells die off quickly upon exposure to erythromycin and the growth curves 
resemble those of CsgG alone. The F68S mutant, however, does confer erythromycin 
resistance, conferring a rescue effect even slightly greater than that of wild type (Figure 7).  
Since the F68S mutant is able to confer erythromycin resistance, it appears that the 
gating mechanism with CsgG is not impaired by the mutation. In fact, since the F68S displayed 
slightly more rescue ability than WT CsgE, it is possible that the gating is even more long-lived 
or robust than with the wild type. This evidence supports the hypothesis that the F68S mutant 
is able to block the CsgG pore, but perhaps is doing so in a way that does not allow CsgA 
through effectively. The W49S and W52S mutants, on the other hand, displayed no rescue 
ability, suggesting that these mutations interfere with CsgE’s ability to interact with CsgG. If 
these mutations decrease the affinity of CsgE with CsgG or otherwise hinder them from forming 
a complex, then the CsgG pore would remain ungated, allowing erythromycin to enter the cell. 
The increased permissivity of the pore would also permit CsgA to diffuse out of the cell, 
resulting in the robust Congo red binding phenotype (Figure 3BC).  
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Western blot was also performed on the cells that underwent the erythromycin assays 
in order to evaluate the levels of CsgG and CsgE. CsgG levels were fairly uniform between all the 
strains evaluated. CsgE levels were uniform for the cells that were not treated with 
erythromycin, but the W49S and W52S mutants that were treated with erythromycin had 
significantly lower levels of CsgE (Figure 8). This is likely due to the fact that these mutants were 
susceptible to erythromycin, and the cells were collected at the end of the assay when they had 
been exposed to erythromycin for 3 hours. Erythromycin acts by interfering with protein 
synthesis [22], thus, the erythromycin-killed cells would be unable to synthesize more CsgG and 
CsgE. CsgG, which remains in the membrane, would be intact even after pelleting the cells and 
appears on the Western Blot. CsgE, on the other hand, would be in the supernatant after 
pelleting, and does not show up in the Western. A faint band is visible for CsgE for the wild type 
and F68S cells, which were resistant to erythromycin.  
All three of these sites have been shown to play important roles in the function of CsgE, 
as examined through Congo red binding, Western blot, and erythromycin sensitivity assays. The 
W49S and W52S mutants were not able to block the CsgG pore, yet were able to complement 
to form robust curli fibers, suggesting that these residues are important in the CsgE-CgG 
interaction. The F68S mutant displayed impaired curli formation yet was highly effective at 
gating the CsgG pore to confer erythromycin resistance. The F68S mutant also appeared more 
stable on Western blot. Thus, this mutation appears to be increasing the stability of the protein 
in a way that causes it to block CsgG and reduce the secretion of CsgA.  
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FUTURE DIRECTIONS 
In order to consider the role these sites play in the interaction between CsgE and CsgA, 
future experiments could evaluate the ability of these CsgE mutants to inhibit CsgA 
polymerization. WT CsgE has been shown to inhibit CsgA polymerization at a near 1:1 molar 
ratio[19]. Since the W49S and W52S mutants displayed a Congo red binding phenotype 
comparable to wild type (Figure 3BC), this may indicate that these mutations still permit normal 
interaction with CsgA. If this is the case, these mutants should be able to inhibit CsgA 
polymerization at similar molar ratios to wild type. However, the W49S and W52S mutants 
were also susceptible to erythromycin in the erythromycin sensitivity assays (Figure 6AB). It is 
possible that since these mutants have impaired interactions with CsgG, the pore is more 
permissive, and the CsgE mutants do not need to interact with CsgA at all.  
The F68S mutant displayed an intermediate Congo red binding phenotype (Figure 3D), 
and cells containing this mutation displayed less CsgA on Western Blot (Figure 4F). Thus, one 
possibility is that the mutation at this site hinders the ability of CsgE to interact with CsgA. If this 
mutant is unable to secrete CsgA normally, then perhaps it will not be able to inhibit CsgA 
polymerization. On the other hand, since the F68S mutant displayed increased rescue ability in 
the erythromycin sensitivity assay (Figure 6C), perhaps the decrease in CsgA secretion is a 
secondary effect of the F68S mutant’s increased ability to block the CsgG pore. Measuring the 
ability of these mutants to inhibit CsgA polymerization would provide a better understanding of 
the role these sites play in interacting with CsgA.  
CsgA polymerization can be measured using thioflavin T (ThT), a fluorescent dye that 
binds to amyloid fibers [15]. The assay would be performed by incubating purified CsgE mutants 
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with purified CsgA and measuring fluorescence over time with ThT. If the above predictions are 
correct, decreased fluorescence should be observed when CsgA is incubated with the W49S and 
W52S mutants, as they inhibit polymerization. If increased polymerization is observed with the 
F68S mutant, then the mutation at this site hinders the ability of CsgE to inhibit CsgA 
polymerization, suggesting that this site is important for interactions between the two proteins. 
However, if the F68S mutant also displays decreased fluorescence, then this mutation may not 
interfere with the ability of CsgE to inhibit CsgA polymerization, suggesting that perhaps the 
decrease in curli fiber formation is a result of the F68S mutant blocking the CsgG pore and 
preventing secretion of CsgA.  
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CONCLUSION 
CsgE presents a promising area of future research into the mechanisms behind curli 
fiber secretion and formation. Three sites of interest have been identified that may play 
important roles in how CsgE interacts with other proteins involved in curli biogenesis. W49S 
and W52S mutations resulted in a Congo red binding phenotype comparable to wild type, 
demonstrating that mutations at these sites still permit CsgA secretion and curli fiber 
formation. However, the W49S and W52S mutations were unable to confer erythromycin 
resistance in erythromycin sensitivity assays. Thus, mutations at these sites interfere with the 
ability of CsgE to block or form a complex with the CsgG pore, suggesting that these sites are 
important for interactions between CsgE and CsgG. However, since these mutants were still 
able to form curli fibers, it may be the case that these mutants are unable to block the CsgG 
pore, keeping it open and allowing CsgA to diffuse across the outer membrane.  
The third site assessed was at the 68th amino acid. A Phe-Ser mutation here resulted in 
impaired curli fiber formation, as seen through an intermediate pink phenotype on Congo red. 
Evaluation of CsgE levels via Western blot also revealed that the F68S mutant was present in 
greater quantities, indicating that this mutation may be making CsgE more stable. When the 
erythromycin sensitivity assay was performed, the F68S mutant conferred as much or even 
greater erythromycin resistance than WT CsgE. Thus, the mutation at this site may be changing 
the stability of the protein in a way that enhances its ability to block the CsgG pore while not 
allowing CsgA to be secreted normally.  
While more research is necessary to gain a better understanding of the gating 
mechanism that occurs between CsgE and CsgG, it appears that all three sites play a role in this 
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interaction, particularly residues 49 and 52. Assays for CsgA polymerization could also be 
performed to evaluate how these mutants interact with CsgA. An understanding of how these 
sites affect the function of CsgE allows for a better understanding of the steps and regulations 
involved in curli secretion and formation, and thus potential targets for their inhibition.  
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